Searched for
BAYERS BOARD
Bill Anderson to become new CEO of BayerBill Anderson is set to take charge as the CEO of Bayer.- Bayer closes sale of Environmental Science Professional business to international private equity firm Cinven“The conditions for closing the transaction – including the receipt of regulatory approval – have now been met. The purchase price for the ...
- Bayer CropScience adds 2% as Cinven to buy environmental biz for $2 billion“This divestment represents a very attractive purchase price and allows us to focus on our core agricultural business and the successful im...
- Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billionGermany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone payments contingent on development achievements...
- Bayer Chairman quits after making progress to settle litigationBayer, which is fighting claims its weedkiller Roundup causes cancer, said its Chairman Werner Wenning was stepping down because the drugs ...
- Bayer to complete acquisition of Monsanto on June 7In India, both entities have presence in production and sale of vegetable seeds, cotton seeds as well as in production and sale of non-sele...
- Bayer to sell selected crop science biz to BASF for $7 billion"In light of the planned acquisition of Monsanto, Bayer has signed an agreement to sell selected Crop Science businesses to BASF for EUR 5....
- Bayer to acquire Monsanto for $66 billion all-cash dealBoth Bayer and Monsanto have presence in India with the US firm selling genetically modified (GM) cotton seeds in the country for more than...
- Monsanto to consider Bayer's revised proposal for acquisitionBayer had raised its all-cash offer to Monsanto shareholders from $ 122 to $ 125/share. It also offered a $ 1.5-billion reverse anti-trust ...
- Bayer CropScience appoints Pankaj Patel as chairmanBayer CropScience informed that the board appointed Pankaj Patel as an additional non-executive director of the company with effect from Ju...
- Vijay Mallya resigns as Chairman of Bayer CropScienceMallya, who was appointed Chairman of the Board in March 2004, will cease to be the Chairman and Director with effect from June 30, Bayer C...
- Vijay Mallya on three-month watch at Bayer CropScienceVijay Mallya assured the board that he would settle dues with the banks and denied allegations of money laundering.
- United Breweries, Sanofi India and Bayer CropScience boards to go with Vijay Mallya as chairmanSeveral members said until they receive any government or regulator's notice questioning Mallya's position they have no plans to ask him to...
- Bayer CropScience Q3 net profit up 41% at Rs 55 croreBayer CropScience today reported 41 per cent increase in net profit at Rs 55 crore for the quarter ended December 31.
- Bayer to focus on life science business, spin off polymer divisionThe aim would be to continue the positive development of these activities in the future through further investment in growth, the statement...
- Natco’s compulsory licence for selling generic copies of Bayer’s cancer drug Nexavar upheld by IpabThe Indian patents appeals board had last year dismissed Bayer’s petition seeking a stay on the “compulsory licence” issued to Natco.
- Bayer says it will defend its intellectual property rights on cancer drugBayer today said it will continue to defend its IP rights while expressing disappointment at the IPAB decision to reject the firm's plea to...
- Intellectual Property Appellate Board postpones Bayer's compulsory licence appealIPAB has postponed German company Bayer AG's appeal against the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma ...
- Bayer challenges Nexavar generic licence orderBayer has filed an appeal against a patents order, which allowed domestic drug maker Natco Pharma to sell a generic version of the German f...
- Bayer's diagnostics unit sold to SiemensBayer, the German group that makes Aspirin, has sold its diagnostics unit to the conglomerate Siemens to reduce debt and refocus its health...
Load More
